Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

MYLOTARG™ Dosage Forms and Strengths (gemtuzumab ozogamicin)

3 DOSAGE FORMS AND STRENGTHS

For injection: 4.5 mg as a white to off-white lyophilized cake or powder in a single-dose vial for reconstitution and further dilution.

Did you find an answer to your question? Yes No

Resources

Didn’t find what you were looking for? Contact us.
Report Adverse Event